The proteins of the Hepatitis C virus: Their features and interactions with intracellular protein phosphorylation

Archives of Virology

Volumn 148, Issue 7, 2003, Pages 1247-1267

  Schulze Zur Wiesch, J ^a   Schmitz, H ^b   Borowski, E ^b   Borowski, Peter ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS;

EID: 0037593310     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-003-0115-8     Document Type: Short Survey

References (123)

1. Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O (2000) Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol 74: 1736-1741
2. Asabe SI, Tanji Y, Satoh S, Kaneko T, Kimura K, Shimotohno K (1997) The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A dependent phosphorylation. J Virol 71: 790-796
3. Banerjee R, Dasgupta A (2001) Specific interaction of hepatitis C virus protease/helicase NS3 with the 3′-terminal sequences of viral positive- and negative-strand RNA. J Virol 75: 1708-1721
4. Barba G, Harper F, Harada T, Kohara M, Goulinet S, Matsuura Y, Eder G, Schaff Z, Chapman MJ, Miyamura T, Brechot C (1997) Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci USA 94: 1200-1205
5. Bartenschlager R, Ahlborn-Laake L, Mous J, Jacobsen H (1994) Kinetic and structural analyses of hepatitis C virus polyprotein processing. J Virol 68: 5045-5055
6. Bartenschlager R (1997) Candidate targets for hepatitis C virus specific antiviral therapy. Intervirology 40: 378-393
7. Behrens SE, Tomei L, De Francesco R (1996) Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J 15: 12-22
8. Blight KJ, Rice CM (1997) Secondary structure determination of the conserved 98-base sequence at the 3′ terminus of hepatitis C virus genome RNA. J Virol 71: 7345-7352
9. Borowski P, Heiland M, Oehlmann K, Becker B, Kornetzky L, Feucht H-H, Laufs R (1996) Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. Eur J Biochem 237: 611-618
10. Borowski P, Oehlmann K, Heiland M, Laufs R (1997) Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free catalytic subunit of cyclic AMP-dependent protein kinase. J Virol 71: 2838-2843
11. Borowski P, Schulze zur Wiesch J, Resch K, Feucht H, Laufs R, Schmitz H (1999) Protein Kinase C Recognizes the Protein Kinase A-binding Motif of Nonstructural Protein 3 of Hepatitis C virus. J Biol Chem 274: 30722-30728
12. Borowski P, Heiland M, Feucht H, Laufs R (1999) Characterisation of non-structural protein 3 of hepatitis C virus as modulator of protein phosphorylation mediated by PKA and PKC. Evidences for action on the level of substrate and enzyme. Arch Virol 144: 687-701
13. Borowski P, Resch K, Laufs R, Schmitz H, Heiland M (2000) Synthetic peptide derived from non-structural protein 3 of hepatitis C virus serves as a substrate specific for PKC. Biol Chem 381: 19-27
14. Boulestin A, Sandres-Saune K, Payen JL, Alric L, Dubois M, Pasquier C, Vinel JP, Pascal JP, Puel J, Izopet J (2002) Genetic heterogeneity of the envelope 2 gene and eradication of hepatitis C virus after a second course of interferon-alpha. J Med Virol 68: 221-228
15. Bukh J, Miller RH, Purcell RH (1995) Genetic heterogenity of hepatitis C virus; Quasispecies and genotypes. Sem Liver Dis 15: 41-63
16. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO (1996) Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77-85
17. Carrere-Kremer S, Montpellier-Pala C, Cocquerel L, Wychowski C, Penin F, Dubuisson J (2002) Subcellular localization and topology of the p7 polypeptide of hepatitis C virus. J Virol 76: 3720-3730
18. Chen CJ, Kuo MD, Chien LJ, Hsu SL, Wang YM, Lin JH (1997) RNA-protein interactions: involvement of NS3, NS5, and 3′ noncoding regions of Japanese encephalitis virus genomic RNA. J Virol 71: 3466-3473
19. Choo Q-L, Kuo G, Weiner AJ, Bradley DW, Houghton M (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244: 359-362
20. Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M (1990) Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 46: 423-441
21. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U, Mosca M, Filliponi F, Brunetto RM, Bonino F, Abrignani S, Valiante NM (2002) Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 195: 35-41
22. Delhem N, Sabile A, Gajardo R, Podevin P, Abadie A, Blaton MA, Kremsdorf D, Beretta L, Brechot C (2001) Activation of the interferon inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene 20: 5836-5845
23. van Doom J (1994) Molecular Biology of the Hepatitis C Virus. J Med Virol 43: 345-356
24. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C (1996) Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334: 77-81
25. Erhardt A, Hassan M, Heintges T, Häusinger D (2002) Hepatitis C virus core protein induces cell proliferation and activates ERK, JNK, and p38 MAP Kinases together with the MAP kinase phosphatase MKP-1 in a HepG2 Tet-off cell line. Virology 292: 272-284
26. Favre D, Berthillon P, Trepo C (2001) Removal of cell-bound lipoproteins: a crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. C R Acad Sci III 324: 1141-1148
27. Fu H, Subramanian RR, Masters SC (2000) 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 40: 617-647
28. Gale M Jr, Blakely CM, Kwieciszewski B, Tan SL, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG (1998) Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18: 5208-5218
29. Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG (1999) Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase. J Virol 73: 6506-6516
30. Gallinari P, Brennan D, Nardi C, Brunetti M, Tomei L, Steinköhler C, De Francesco R (1998) Multiple enzymatic activities associated with recombinant NS3 protein of hepatitis C virus. J Virol 72: 6758-6769
31. Gong G, Waris G, Tanveer R, Siddiqui A (2001) Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. Proc Natl Acad Sci USA 98: 9599-9604
32. Gordon FD, Poterucha JJ, Germer J, Zein NN, Batts KP, Gross JB Jr, Wiesner R, Persing D (1997) Relationship between hepatitis C genotype and severity of recurrent hepatitis C after live transplantation. Transplantation 63: 1419-1423
33. Grakoui A, Wychowski C, Lin C, Feinstone SM, Rice CM (1993) Expression and identification of hepatitis C virus polyprotein cleavage products. J Virol 67: 1385-1395
34. Gu B, Liu C, Lin-Goerke J, Maley DR, Gutshall LL, Fletenberger CA, Del Vecchio A (2000) The RNA helicase and nucleotide triphosphatase activities of the bovine viral diarrhea virus NS3 protein are essential for viral replication. J Virol 74: 1794-1800
35. Hadziyannis SJ (1997) The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 1: 9-28
36. Hijikata M, Mizushima H, Tanji J, Komoda Y, Hirowatari Y, Akagi T, Kato T, Kimura K, Shimotohno K (1993) Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus. Proc Natl Acad Sci USA 90: 10773-10777
37. Hijikata M, Mizushima H, Akagi T, Mori S, Kakiuchi N, Kato N, Tanaka T, Kimura K, Shimotohno K (1993) Two distinct proteinase activities required for the processing of putative nonstructural precursor protein of hepatitis C virus. J Virol 67: 4665-4675
38. Hirano M, Kaneko S, Yamashita T, Luo H, Qin W, Shirota Y, Nomura T, Kobayashi K, Murakami S (2003) Direct interaction between nucleolin and hepatitis C virus NS5B. J Biol Chem 278: 5109-5115
39. Hwang SB, Park KJ, Kim YS, Sung YC, Lai MM (1997) Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology 227: 439-446
40. Ide Y, Zhang L, Chen M, Inchauspe G, Bahl C, Sasaguri Y, Padmanabhan R (1996) Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. Gene 182: 203-211
41. Ide Y, Tanimoto A, Sasaguri Y, Padmanabhan R (1997) Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-alpha catalytic subunit. Gene 201: 151-158
42. Ishido S, Fujita T, Hotta H (1998) Complex formation of NS5B with NS3 and NS4A proteins of herpatitis C virus. Biochem Biophys Res Commun 244: 35-40
43. Ito Y, Sasaki Y, Horimoto M, Wada S, Tanaka Y, Kasahara A, Ueki T, Hirano T, Yamamoto H, Fujimoto J, Okamoto E, Hayashi N, Hori M (1998) Activation of mitogen-activated protein kinases/extracellular signal regulated kinases in human hepatocellular carcinoma. Hepatology 27: 951-958
44. Jung EY, Lee MN, Yang HY, Yu D, Jang KL (2001) The repressive activity of hepatitis C virus core protein on the transcription of p21(waf1) is regulated by protein kinase A-mediated phosphorylation. Virus Res 79: 109-115
45. Kapoor M, Zhang L, Ramachandra M, Kusukawa J, Ebner KE, Padmanabhan R (1995) Association between NS3 and NS5 proteins of dengue virus type 2 in the putative RNA replicase is linked to differential phosphorylation of NS5. J Biol Chem 270: 19100-19106
46. Kato N, Lan KH, Ono-Nita SK, Shiratori Y, Omata M (1997) Hepatitis C virus non-structural region 5A protein is a potent transcriptional activator. J Virol 71: 8856-8859
47. Katze MG, Kwieciszewski B, Goodlett DR, Blakely CM, Neddermann P, Tan SL, Aebersold R (2000) Ser2194 is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. Virology 278: 501-513
48. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron JP, Lunel F, Stuyver L, Duverlie G (1997) Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatol 27: 72-77
49. Kim JL, Morgenstern KA, Lin C, Fox T, Dwyer MD, Landro JA, Chambers SP, Markland W, Lepre CA, O'Malley ET, Harbeson SL, Rice CM, Murcko MA, Caron PR, Thomson JA (1996) Crystal structure of the hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell 87: 343-355
50. Kim J, Lee D, Choe J (1999) Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. Biochem Biophys Res Commun 257: 777-781
51. Kumar A, Yang YL, Flati V, Der S, Kadereit S, Deb A, Haque J, Reis L, Weissmann C, Williams BR (1997) Deficient cytokine signalling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J 16: 406-416
52. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C (1997) Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy. Hepatology 25: 750-753
53. Labonte P, Axelrod V, Agarwal A, Aulabaugh A, Amin A, Mak P (2002) Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis. J Biol Chem 277: 38838-38846
54. Levy S, Todd SC, Maecker HT (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu Rev Immunol 16: 89-109. Review
55. Leyssen P, De Clercq E, Neyts J (2000) Perspectives for the treatment of infections with Flaviviridae. Clin Microbiol Rev 13: 67-82
56. Lin C, Lindenbach BD, Pragai BM, McCourt DW, Rice CM (1994) Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol 68: 5063-5073
57. Lin C, Pragai B, Grakoui A, Xu J, Rice CM (1994) Hepatitis C virus serine proteinase: trans cleavage requirement and processing kinetics. J Virol 68: 8147-8157
58. Lin C, Wu JW, Hsiao K, Su MS (1997) The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J Virol 71: 6465-6471
59. Liu Q, Bhat RA, Prince AM, Zhang P (1999) The hepatitis C virus NS2 protein generated by NS2-3 autocleavage is required for NS5A phosphorylation. Biochem Biophys Res Commun 254: 572-577
60. Lo S-Y, Selby M, Tong M, Ou J-H (1994) Comparative studies of the core gene products of two different hepatitis C virus isolates: Two alternative forms determined by a single amino acid substitution. Virology 199: 124-131
61. Lo S-Y, Masiarz F, Hwang SB, Lai MMC, Ou J-H (1995) Differential subcellular localization of hepatitis C virus core gene products. Virology 213: 455-461
62. Lohmann V, Ross A, Korner F, Koch JO, Bartenschlager R (1998) Biochemical and kinetic analyses of NS5B RNA-dependent RNA polymerase of the hepatitis C virus. Virology 249: 108-118
63. Lu W, Ou JH (2002) Phosphorylation of hepatitis C virus core protein by protein kinase A and protein kinase C. Virology 300: 20-30
64. Matsuura Y, Harada T, Makimura M, Sato M, Aizaki H, Suzuki T, Miyamura T (1994) Characterization of HCV structural proteins expressed in various animal cells. Intervirology 37: 114-118
65. Masters SC, Fu H (2001) 14-3-3 Proteins mediate an essential anti apoptotic signal. J Biol Chem 276: 45193-45200
66. Matsumoto M, Hwang SB, Jeng KS, Zhu N, Lai MM (1996) Homotypic interaction and multimerization of hepatitis C virus core protein. Virology 218: 43-51
67. Matusan AE, Pryor MJ, Davidson AD, Wright PJ (2001) Mutagenesis of the dengue virus type 2 NS3 protein within and outside helicase motifs: effects on enzyme activity and virus replication. J Virol 75: 9633-9643
68. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK (1998) Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 339: 1485-1492
69. Meurs EF, Galabru J, Barber GN, Katze MG, Hovanessian AG (1993) Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90: 232-236
70. Michalak JP, Wychowski C, Choukhi A, Meunier JC, Ung S, Rice CM, Dubuisson J (1997) Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78: 2299-2306
71. Miller RH, Purcell RH (1990) Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 87: 2057-2061
72. Mizokami M, Orito E (1999) Molecular evolution of hepatitis viruses. Intervirology 42: 159-165
73. Mochly-Rosen D, Khaner H, Lopez J (1991) Identification of intracellular receptor proteins for activated protein kinase C. Proc Natl Acad Sci USA 88: 3997-4000
74. Monath TP, Heinz FX (1996) Flaviviruses, p. 961-1034. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology 3rd edn, vol. 1. Lippincott Raven Publishers, Philadelphia, PA
75. Morgenstern KA, Landro JA, Hsiao K, Lin C, Young G, Su M-S, Thomson JA (1997) Polynucleotide modulation of the protease, nucleoside triphosphatase, and helicase activities of hepatitis C virus NS3-NS4A complex. J Virol 71: 3767-3775
76. Neddermann P, Clementi A, De Francesco R (1999) Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B, and NS5A encoded on the same polyprotein. J Virol 73: 9984-9991
77. Okada S, Akahane Y, Suzuki H, Okamoto H, Mishiro S (1992) The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16: 619-624
78. Pallaoro M, Lahm A, Biasiol G, Brunetti M, Nardella C, Orsatti L, Bonelli F, Orru S, Narjes F, Steinkuhler C (2001) Characterization of the hepatitis C virus NS2/3 processing reaction by using a purified precursor protein. J Virol 75: 9939-9946
79. Piccininni S, Varaklioti A, Nardelli M, Dave B, Raney KD, McCarthy JE (2002) Modulation of the hepatitis C virus RNA-dependent RNA polymerase activity by the non-structural (NS) 3 helicase and the NS4B membrane protein. J Biol Chem 277: 45670-45679
80. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S (1998) Binding of hepatitis C virus to CD81. Science 282: 938-941
81. Polyak SJ, McArdle S, Liu SL, Sullivan DG, Chung M, Hofgartner WT, Carithers RL Jr, McMahon BJ, Mullins JI, Corey L, Gretch DR (1998) Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection. J Virol 72: 4288-4296
82. Poole TL, Wang C, Popp RA, Potgieter LN, Siddiqui A, Collett MS (1995) Pestivirus translation initiation occurs by internal ribosome entry. Virology 206: 750-754
83. Poynard T, Marcellin P, Lee S, Niederau C, Minuk GS, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J (1998) Randomised trial of interferon alpha-2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha-2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 352: 1426-1432
84. Poynard T, Ratziu V, Benhamou Y, Opolon P, Cacoub P, Bedossa P (2000) Natural history of HCV infection. Baillieres Best Pract Res Clin Gastroenterol 14: 211-228
85. Proud CG (1995) PKR: a new name and new roles. Trends Biochem Sci 20: 241-246
86. Pryor MJ, Gualano RC, Lin AD, Davidson AD, Wright PJ (1998) Growth restriction of dengue virus type 2 by site-specific mutagenesis of virus encoded glycoproteins. J Gen Virol 79: 2631-2639
87. Racker E (1992) Chaperones and matchmakers: inhibitors and stimulators of protein phosphorylation. Curr Top Cell Regul 33: 127-143
88. Ravaggi A, Natoli G, Primi D, Albertini A, Levrero M, Cariani E (1994) Intracellular localization of full-length and truncated hepatitis C virus core protein expressed in mammalian cells. J Hepatol 20: 833-836
89. Ray RB, Lagging LM, Meyer K, Steele R, Ray R (1995) Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res 37: 209-220
90. Ray RB, Lagging LM, Meyer K, Ray R (1996) Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 70: 4438-4443
91. Ray RB, Meyer K, Ray R (1996) Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226: 176-182
92. Ray RB, Steele R, Meyer K, Ray R (1997) Transcriptional Repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272: 10983-10986
93. Ray RB, Ray R (2001) Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol Lett 202: 149-156
94. Reed KE, Grakoui A, Rice CM (1995) The hepatitis C virus NS2-3 autoproteinase: cleavage site mutagenesis and requirements for biomolecular cleavage. J Virol 69: 4127-4136
95. Reed KE, Xu J, Rice CM (1997) Phosphorylation of the hepatitis C virus NS5A protein in vivo and in vitro: properties of the NS5A-associated kinase. J Virol 71: 7187-7197
96. Reed KE, Rice CM (1999) Identification of the major phosphorylation site of the hepatitis C virus H strain NS5A protein as serine2321. J Biol Chem 274: 28011-28018
97. Reyes GR (2002) The nonstructural NS5A protein of hepatitis C virus: an expanding, multifunctional role in enhancing hepatitis C virus pathogenesis. J Biomed Sci 9: 187-197
98. Rice MC (1996) Flaviviridae: the viruses and their replication, p. 931, 960. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology 3rd edn, vol. 1. Lippincott-Raven Publishers, Philadelphia, PA
99. Romano PR, Garcia-Barrio MT, Zhang X, Wang Q, Taylor DR, Zhang F, Herring C, Mathews MB, Qin J, Hinnebusch AG (1998) Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol Cell Biol 18: 2282-2297
100. Rommel C, Radziwill G, Lovric J, Noeldeke J, Heinicke T, Jones D, Aitken A, Moelling K (1996) Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1. Oncogene 12: 609-619
101. Saito S, Kato N, Hijikata M, Gunji T, Itabashi M, Kondo M, Tanaka K, Shimotohno K (1996) Comparison of hypervariable regions (HVR1 and HVR2) in positive- and negative-stranded hepatitis C virus RNA in cancerous and non cancerous liver tissue, peripheral blood mononuclear cells and serum from a patient with hepatocellular carcinoma. Int J Cancer 67: 199-203
102. Santolini E, Pacini L, Fipaldini C, Migliaccio G, Monica N (1995) The NS2 protein of hepatitis C virus is a transmembrane polypeptide. J Virol 69: 7461-7471
103. Satoh S, Hirota M, Noguchi T, Hijikata M, Handa H, Shimotohno K (2000) Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. Virology 270: 476-487
104. Shih C-M, Lo SJ, Miyamura T, Chen S-Y, Lee YH (1993) Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HUH-7 cells. J Virol 67: 5823-5832
105. Shih C-M, Chen C-M, Chen S-Y, Lee YH (1995) Modulation of the trans suppression activity of hepatitis C virus core protein by phosphorylation. J Virol 69: 1160-1171
106. Shirota Y, Luo H, Qin W, Kaneko S, Yamashita T, Kobayashi K, Murakami S (2002) Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity. J Biol Chem 277: 11149-11155
107. Srinivas RV, Ray RB, Meyer K, Ray R (1996) Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication. Virus Res 45: 87-92
108. Suzich J, Tamura J, Palmer-Hill F, Warrener P, Grakoui A, Rice MC, Feinstone S, Collett M (1993) Hepatitis C virus NS3 protein polynucleotide stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes. J Virol 67: 6152-6158
109. Tan SL, Nakao H, He Y, Vijaysri S, Neddermann P, Jacobs BL, Mayer BJ, Katze MG (1999) NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. Proc Natl Acad Sci USA 96: 5533-5538
110. Tanji Y, Kaneko T, Satoh S, Shimotohno K (1995) Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J Virol 69: 3980-3986
111. Taylor DR, Shi ST, Romano PR, Barber GN, Lai MC (1999) Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. Science 285: 107-110
112. Taylor DR, Tian B, Romano PR, Hinnebusch AG, Lai MM, Mathews MB (2001) Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain. J Virol 75: 1265-1273
113. Tseng CT, Klimpel GR (2002) Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 195: 43-49
114. Tsukiyama-Kohara K, Iizuka N, Kohara M, Nomoto A (1992) Internal ribosome entry site within hepatitis C virus RNA. J Virol 66: 1476-1483
115. Tzivion G, Luo Z, Avruch J (1998) A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity. Nature 394: 88-92
116. Wack A, Soldaini E, Tseng C, Nuti S, Klimpel G, Abrignani S (2001) Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co stimulatory signal for human T cells. Eur J Immunol 31: 166-175
117. Westeway EG (1987) Flavivirus replication strategy. Adv Virus Res 33: 45-90
118. Yamaga AK, Ou JH (2002) Membrane topology of the hepatitis C virus NS2 protein. J Biol Chem 277: 33228-33234
119. Yamashita T, Kaneko S, Shirota Y, Qin W, Nomura T, Kobayashi K, Murakami S (1998) RNA-dependent Rna polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J Biol Chem 273: 15479-15486
120. Yao ZQ, Nguyen DT, Hiotellis AI, Hahn YS (2001) Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway. J Immunol 167: 5264-5272
121. Yoshida T, Hanada T, Tokuhisa T, Kosai K, Sata M, Kohara M, Yoshimura A (2002) Activation of STAT3 by the hepatitis C virus core protein leads to cellular transformation. J Exp Med 196: 641-653
122. Zhao LJ, Liu HQ, Cao J, Feng GS, Qi ZT (2001) Activation of intracellular MAPK/ERK initiated by hepatitis C virus envelope protein E2 in HepG2 cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 33: 691-695
123. Zhong W, Ingravallo P, Wright-Minogue J, Skelton A, Uss AS, Chase R, Yao N, Lau, YN, Hong Z (1999) Nucleoside triphosphatase and RNA helicase activities associated with GB virus B nonstructural protein 3. Virology 261: 216-226